Michael Milos Thornton, Chief Technology Officer at ENDRA Life Sciences Inc. (NDRA), bought 25,000 shares at $0.21 ($5K) on 2022-05-26, disclosed to the SEC on 2022-05-31.
Open-market purchase of $5k NDRA by Chief Technology Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| NDRA | BUY | 2022-08-24 | $5K | — | Filing → |
| NDRA | BUY | 2022-05-23 | $6K | — | Filing → |
| NDRA | SELL | 2021-04-07 | $82K | — | Filing → |